Assessing Vermilion Energy (TSX:VET) Valuation As Sentiment Strengthens Despite Net Loss And Higher Shareholder Returns

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.

Vermilion Energy (TSX:VET) is back in focus after reporting a full year 2025 net loss alongside higher revenue, while also raising its dividend, issuing 2026 production guidance and completing a share buyback tranche.

See our latest analysis for Vermilion Energy.

Those 2025 results, the higher dividend and the ongoing buyback come after a strong run in the share price. Vermilion Energy’s 30 day share price return of 18.39% and 1 year total shareholder return of 52.77% suggest momentum has been building recently.

If this mix of earnings volatility and shareholder returns has your attention, it could be a good moment to look at other energy related opportunities. You can use our screener of 87 nuclear energy infrastructure stocks as a starting point.

So with Vermilion trading at CA$16.16, currently above a CA$15.82 analyst price target yet still showing an estimated intrinsic discount of about 53%, should you view this as potential underpriced value, or is the market already accounting for future growth expectations in the share price?

With Vermilion Energy’s CA$15.41 fair value estimate sitting slightly below the CA$16.16 share price, the current narrative sees the stock a touch ahead of its modeled value, built on higher growth and margin assumptions but paired with a lower future valuation multiple.

Vermilion’s capital program includes significant investments in new growth projects in Germany, Croatia, and the B.C. Montney, expected to contribute strong free cash flow in future years, positively impacting revenue. Vermilion’s discovery and development of German deep gas exploration wells, particularly with successful wells like Wisselshorst, are expected to more than double current European 2P gas reserves. This could significantly boost revenue and increase earnings over the coming years through higher production and premium European gas prices.

Read the complete narrative.

Curious what turns those European gas projects, margin assumptions and a trimmed future P/E into a CA$15.41 fair value? The full narrative connects the dots between projected revenue, profitability and the discount rate that brings all those future cash flows back to today’s CA$16.16 price debate.

Result: Fair Value of CA$15.41 (OVERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, this hinges on smooth integration of the Westbrick assets and successful execution of capital intensive European gas projects, where any stumble could challenge these fair value assumptions.

Find out about the key risks to this Vermilion Energy narrative.

Our DCF work presents Vermilion as good value, with the share price at CA$16.16 trading about 53% below an estimated CA$34.40 future cash flow value. This contrasts with the CA$15.41 fair value from the narrative. The question is which yardstick you place more weight on right now.

Look into how the SWS DCF model arrives at its fair value.

If this mix of opportunity and concern leaves you on the fence, it is worth looking through the numbers yourself and deciding where you stand. Our breakdown of 3 key rewards and 3 important warning signs can help you weigh both sides before you act.

If you are weighing what to do next, use this as a prompt to widen your search and line up fresh ideas before the market moves on.

• Target income first and review high yield opportunities using our list of 6 dividend fortresses that focus on robust payouts for shareholders.

• Hunt for mispriced quality and scan our 9 high quality undervalued stocks to spot companies that combine strong fundamentals with potentially attractive entry points.

• Prioritise resilience and stress test your watchlist against our 8 resilient stocks with low risk scores that highlights businesses with lower overall risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include VET.TO.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com